Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SWITCH 2
2011-004396-36Phase 3Completed
- Sponsor
- Technical University of Munich Faculty of Medicine
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sorafenib, pazopanib in renal cell carcinoma (RCC), sponsored by Technical University of Munich Faculty of Medicine. Started Dec 2011; status: completed.
02
Drugs
sorafenibpazopanib
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on 2011-004396-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004396-36.